File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/jbm.b.31582
- Scopus: eid_2-s2.0-77949527777
- PMID: 20091923
- WOS: WOS:000275796700028
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Synthesis, in vitro hydroxyapatite forming ability, and cytocompatibility of strontium silicate powders
Title | Synthesis, in vitro hydroxyapatite forming ability, and cytocompatibility of strontium silicate powders | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Keywords | Cytocompatibility Hydroxyapatite forming ability Hydroxyapatite forming ability | ||||||||
Issue Date | 2010 | ||||||||
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.interscience.wiley.com/jpages/0021-9304:1/ | ||||||||
Citation | Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2010, v. 93 n. 1, p. 252-257 How to Cite? | ||||||||
Abstract | Phase-pure strontium silicate (SrSiO(3)) powders were synthesized by chemical precipitation method. In vitro bioactivity of the powders were evaluated by examining the hydroxyapatite forming ability on their surface soaking simulated body fluid for various periods. The results showed that SrSiO(3) could induce hydroxy carbonate apatite formation after soaking for 7 days. Both L929 and rabbit bone marrow stromal cells (rMSCs) were used to test the in vitro cytocompatibility of SrSiO(3). L929 culture experiment showed that the ionic product of SrSiO(3) did not exhibit cytotoxicity except at high ion concentrations (Si 3.75 mM and Sr 0.12 mM). Moreover, at certain ion concentrations (Si 1.87-0.12 mM and Sr 0.12-3.75 x 10(-3) mM), the ionic product of SrSiO(3) stimulated the proliferation of rMSCs. All the results indicated that SrSiO(3) might be used as a new bioactive material for bone regeneration applications. © 2010 Wiley Periodicals, Inc. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/129056 | ||||||||
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 0.634 | ||||||||
ISI Accession Number ID |
Funding Information: Contract grant sponsor: Science and Technology Commission of Shanghai Municipality; contract grant numbers: 08JC1420800, 09JC1415500 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, M | en_US |
dc.contributor.author | Zhai, W | en_US |
dc.contributor.author | Lin, K | en_US |
dc.contributor.author | Pan, H | en_US |
dc.contributor.author | Lu, WW | en_US |
dc.contributor.author | Chang, J | en_US |
dc.date.accessioned | 2010-12-23T08:31:57Z | - |
dc.date.available | 2010-12-23T08:31:57Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.citation | Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2010, v. 93 n. 1, p. 252-257 | en_US |
dc.identifier.issn | 1552-4973 | - |
dc.identifier.uri | http://hdl.handle.net/10722/129056 | - |
dc.description.abstract | Phase-pure strontium silicate (SrSiO(3)) powders were synthesized by chemical precipitation method. In vitro bioactivity of the powders were evaluated by examining the hydroxyapatite forming ability on their surface soaking simulated body fluid for various periods. The results showed that SrSiO(3) could induce hydroxy carbonate apatite formation after soaking for 7 days. Both L929 and rabbit bone marrow stromal cells (rMSCs) were used to test the in vitro cytocompatibility of SrSiO(3). L929 culture experiment showed that the ionic product of SrSiO(3) did not exhibit cytotoxicity except at high ion concentrations (Si 3.75 mM and Sr 0.12 mM). Moreover, at certain ion concentrations (Si 1.87-0.12 mM and Sr 0.12-3.75 x 10(-3) mM), the ionic product of SrSiO(3) stimulated the proliferation of rMSCs. All the results indicated that SrSiO(3) might be used as a new bioactive material for bone regeneration applications. © 2010 Wiley Periodicals, Inc. | - |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.interscience.wiley.com/jpages/0021-9304:1/ | - |
dc.relation.ispartof | Journal of Biomedical Materials Research Part B: Applied Biomaterials | en_US |
dc.rights | Journal of Biomedical Materials Research Part B: Applied Biomaterials. Copyright © John Wiley & Sons, Inc. | - |
dc.subject | Cytocompatibility | - |
dc.subject | Hydroxyapatite forming ability | - |
dc.subject | Hydroxyapatite forming ability | - |
dc.subject.mesh | Body Fluids - metabolism | - |
dc.subject.mesh | Bone Substitutes - chemical synthesis - chemistry | - |
dc.subject.mesh | Durapatite - metabolism | - |
dc.subject.mesh | Silicates - chemical synthesis - chemistry | - |
dc.subject.mesh | Strontium - chemistry | - |
dc.title | Synthesis, in vitro hydroxyapatite forming ability, and cytocompatibility of strontium silicate powders | en_US |
dc.type | Article | en_US |
dc.identifier.email | Pan, H: haobo@hku.hk | en_US |
dc.identifier.email | Lu, WW: wwlu@hkusua.hku.hk | en_US |
dc.identifier.authority | Pan, H=rp01564 | en_US |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1002/jbm.b.31582 | - |
dc.identifier.pmid | 20091923 | - |
dc.identifier.scopus | eid_2-s2.0-77949527777 | - |
dc.identifier.hkuros | 176714 | en_US |
dc.identifier.volume | 93 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 252 | en_US |
dc.identifier.epage | 257 | en_US |
dc.identifier.isi | WOS:000275796700028 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1552-4973 | - |